Frankfurt - Delayed Quote EUR
Unilever PLC (UNVA.F)
55.50
-0.50
(-0.89%)
At close: April 25 at 8:04:30 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 20 | 19 |
| Avg. Estimate | 15.26B | 16.76B | 60.95B | 62.44B |
| Low Estimate | 15.22B | 16.76B | 59.06B | 54.8B |
| High Estimate | 15.3B | 16.76B | 63.52B | 65.97B |
| Year Ago Sales | -- | 16.09B | 60.76B | 60.95B |
| Sales Growth (year/est) | -- | 4.16% | 0.32% | 2.43% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UNVA.F | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Downgrade | Erste Group: Buy to Hold | 11/19/2024 |
| Upgrade | B of A Securities: Underperform to Buy | 8/22/2024 |
| Upgrade | JP Morgan: Underweight to Overweight | 5/23/2024 |
| Maintains | Argus Research: Buy to Buy | 5/8/2024 |
| Downgrade | Morgan Stanley: Equal-Weight to Underweight | 2/27/2024 |
| Upgrade | Bernstein: Underperform to Market Perform | 3/14/2022 |